NCT03870256View on ClinicalTrials.gov

Oral Tranexamic Acid Plus Sublingual Misoprostol in Atonic Postpartum Hemorrhage

NACompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

August 1, 2021

Study Completion Date

September 1, 2021

Conditions
Post Partum Hemorrhage
Interventions
DRUG

misoprostol

Patient receive 600mic gm sublingual misoprostol

DRUG

Carbetocin

Patient receive 100 mic gm carbetocin IV

DRUG

TA

The patient receives 1gm oral tranexamic acid

Trial Locations (1)

81528

AswanUH, Aswān

All Listed Sponsors
lead

Aswan University Hospital

OTHER

NCT03870256 - Oral Tranexamic Acid Plus Sublingual Misoprostol in Atonic Postpartum Hemorrhage | Biotech Hunter | Biotech Hunter